BOSTON, March 14, 2012 /PRNewswire/ -- Perceptive
Informatics, a leading eClinical solutions provider and a
subsidiary of PAREXEL International Corporation (NASDAQ: PRXL),
today announced results of its Randomization and Trial Supply
Management (RTSM) Survey, which tracked the evolving use of RTSM
technologies, also known as Interactive Voice and Web Response
Systems (IVRS/IWRS), by investigative sites worldwide. The survey
polled professionals at nearly 300 investigative sites across the
Americas, Europe and Asia. Results revealed a significant level of
adoption of web- over voice-based versions of these
technologies.
Used to randomize patients for study enrollment and manage
various aspects of trial management, web-based RTSM systems provide
investigative sites with the ability to collect and report on study
data in real-time. According to the Perceptive Informatics
analysis, this increased efficiency has provided a competitive
advantage to sites in the selection process of clinical trial
sponsors, who are seeking faster patient enrollment and a track
record of high performance for global studies.
The Perceptive Informatics analysis showed that 65% of
respondents worldwide use web-based RTSM systems to support
clinical study execution. The Asia/Pacific region led all other geographies
with the highest use of web- over voice-based systems, followed by
Europe. In terms of the type of
environment, 68% of hospital-based clinics and 61% of
physician-based sites prefer web-based systems. According to
the Perceptive Informatics survey, the top three reasons cited by
respondents for their preference of web-based RTSM technologies
include ease of use, speed, and convenience. Main uses of
web-based RTSM technologies among investigative sites include drug
accountability, identifying missing or damaged medication, and
making dose adjustments.
"Sponsors are seeking to drive continuous process improvement in
their clinical trial programs, and we have developed our eClinical
solutions to support this goal. The results of this study are
consistent with our commitment to advance flexible, web-based RTSM
technologies," said Nick Richards,
Vice President, Product Development, Perceptive Informatics. "We
are focused on empowering investigative sites to improve their
performance. By harnessing the power of web-based RTSM
technology, sites can simplify their workflows and conduct study
management activities more efficiently."
The ClinPhone® RTSM service from Perceptive
Informatics offers validated randomization methods, automated
inventory control, dispensing and titration management, emergency
code break capabilities, and real-time supply reporting. The
solutions provide sophisticated reporting to monitor trial
management performance, trending and forecasting information, and
in-depth data analysis. Clinical trials worldwide can be supported
in multiple languages through the solutions, which provide secure
access, a detailed audit trail, transaction logging, and compliance
with FDA 21 CFR Part 11.
About Perceptive Informatics
Perceptive Informatics, a leading eClinical solutions provider
and subsidiary of PAREXEL, is focused on helping customers to
accelerate the product development process through innovation.
Perceptive enables customers to maximize the benefits of clinical
trial technologies by providing flexible software-as-a-service
(SaaS) applications and leading technology services. The Perceptive
Informatics eClinical Suite is built on extensive medical and
clinical expertise, as well as a deep understanding of the
regulatory environment. The suite includes Randomization and Trial
Supply Management (RTSM) technologies, Medical Imaging, Clinical
Trial Management Systems (CTMS), Electronic Data Capture (EDC), and
Electronic Patient-Reported Outcomes (ePRO). The Perceptive
Informatics eClinical Suite blurs the boundaries among systems that
traditionally have been used in isolation, resulting in simplified
workflow, improved efficiency and enhanced productivity. For more
information about the integrated solutions in the Perceptive
Informatics eClinical Suite visit www.perceptive.com.
About PAREXEL International
PAREXEL International Corporation is a leading global
biopharmaceutical services organization, providing a broad range of
knowledge-based contract research, consulting, and medical
communications services to the worldwide pharmaceutical,
biotechnology and medical device industries. Committed to providing
solutions that expedite time-to-market and peak-market penetration,
PAREXEL has developed significant expertise across the development
and commercialization continuum, from drug development and
regulatory consulting to clinical pharmacology, clinical trials
management, medical education and reimbursement. Perceptive
Informatics, Inc., a subsidiary of PAREXEL, provides advanced
technology solutions, including medical imaging, to facilitate the
clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71
locations throughout 52 countries around the world, and has
approximately 11,300 employees. For more information about PAREXEL
International visit www.PAREXEL.com.
This release contains "forward-looking" statements regarding
future results and events, including, without limitation,
statements regarding expected financial results, future growth and
customer demand. For this purpose, any statements
contained herein that are not statements of historical fact may be
deemed forward-looking statements. Without limiting the
foregoing, the words "believes," "anticipates," "plans," "expects,"
"intends," "appears," "estimates," "projects," "will," "would,"
"could," "should," "targets," and similar expressions are
also intended to identify forward-looking statements. The
forward-looking statements in this release involve a number of
risks and uncertainties. The Company's actual future results
may differ significantly from the results discussed in the
forward-looking statements contained in this release.
Important factors that might cause such a difference include, but
are not limited to, risks associated with: actual operating
performance; actual expense savings and other operating
improvements resulting from recent and anticipated restructurings,
including the anticipated additional restructuring charges of
approximately $2.0 million in the
third quarter of Fiscal Year 2012; the loss, modification, or delay
of contracts which would, among other things, adversely impact the
Company's recognition of revenue included in backlog; the Company's
dependence on certain industries and clients; the Company's ability
to win new business, manage growth and costs, and attract and
retain employees; the Company's ability to complete additional
acquisitions and to integrate newly acquired businesses or enter
into new lines of business; the impact on the Company's business of
government regulation of the drug, medical device and
biotechnology industry; consolidation within the pharmaceutical
industry and competition within the biopharmaceutical services
industry; the potential for significant liability to clients and
third parties; the potential adverse impact of health care reform;
and the effects of exchange rate fluctuations and other
international economic, political, and other risks.
Such factors and others are discussed more fully in the section
entitled "Risk Factors" of the Company's Quarterly Report on Form
10-Q for the quarter ended December 31,
2011 as filed with the SEC on February 9, 2012, which "Risk Factors" discussion
is incorporated by reference in this press release. The
Company specifically disclaims any obligation to update these
forward-looking statements in the future. These
forward-looking statements should not be relied upon as
representing the Company's estimates or views as of any date
subsequent to the date of this press release.
PAREXEL is a registered trademark of PAREXEL International
Corporation, ClinPhone is a registered trademark of ClinPhone
Limited, and Perceptive Informatics is a trademark of Perceptive
Informatics, Inc. All other names or marks may be registered
trademarks or trademarks of PAREXEL International Corporation,
Perceptive Informatics, Inc. or their respective owners and are
hereby acknowledged.
Contacts:
|
|
Jennifer
Baird, Senior Director of Public Relations
|
Kim
Leadley/Gene Carozza
|
PAREXEL
International
|
PAN
Communications
|
Tel:
+781-434-4409
|
Tel: +
617-502-4300
|
Email:
Jennifer.Baird@PAREXEL.com
|
Email:
PAREXEL@pancomm.com
|
SOURCE PAREXEL International Corporation